Niagen Bioscience NAGE
NASDAQ NAGE
$2.95 +0.00 (+0.17%)
As of: Sep 30, 2026 · 12:50 PM EDT

Niagen Bioscience, Inc. (NAGE) EV to EBIT (2024 - 2026)

Updated

Niagen Bioscience's EV to EBIT was 17.45 in Q2 2026, down 73.2% from 65.17 a year earlier and down 19.6% from the prior quarter.

Analysis

Niagen Bioscience, Inc. (NAGE) EV to EBIT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Niagen Bioscience's EV to EBIT was -1.00 through Jun 30, 2026; for FY2025, it came in at 27.16, down 42.7% from FY2024.

  • In earlier years, EV to EBIT was 47.37 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly EV to EBIT in data going back to Q3 2024.
  • Compared with a year earlier, EV to EBIT has declined for four straight quarters, with an average decline of 62.6% over the last four quarters.
  • Per Business Quant data, NAGE's EV to EBIT in the three quarters before Q2 2026 was 21.70 (Q1 2026), 27.16 (Q4 2025) and 35.16 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.45
Mar 31, 2026 21.70
Dec 31, 2025 27.16
Sep 30, 2025 35.16
Jun 30, 2025 65.17
Mar 31, 2025 36.71
Dec 31, 2024 47.37
Sep 30, 2024 548.32
API Access

Niagen Bioscience, Inc. EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=NAGE&period=max&api_key=YOUR_API_KEY